The FDA issued more stringent rules for COVID-19 antibody tests sold in the U.S., after a slew of tests hit the market without adequate proof that they really work.
FDA releases more stringent rules for COVID-19 antibody tests
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over